Intranasally

Intranasally

Intranasally refers to the administration of substances through the nasal passages. This route of administration is utilized for various medications and treatments due to its rapid absorption and onset of action. The nasal cavity provides a large surface area and a rich blood supply, making it an effective site for drug delivery.

Anatomy and Physiology

The nasal cavity is divided into two nostrils by the nasal septum. It is lined with a mucous membrane and contains structures such as the turbinates, which increase the surface area for absorption. The olfactory region, located at the roof of the nasal cavity, is responsible for the sense of smell and is also a potential site for drug delivery to the central nervous system.

Mechanism of Absorption

Intranasal administration allows drugs to bypass the gastrointestinal tract and first-pass metabolism in the liver. Drugs can be absorbed directly into the systemic circulation through the nasal mucosa. Additionally, the proximity of the nasal cavity to the brain allows for potential direct delivery to the central nervous system via the olfactory and trigeminal nerves.

Advantages

• Rapid Onset: Intranasal administration provides a quick onset of action, which is beneficial for acute conditions such as pain or seizures.
• Non-Invasive: It is a non-invasive route, making it more acceptable to patients who are averse to injections.
• Bypass of First-Pass Metabolism: Drugs administered intranasally avoid first-pass metabolism, potentially increasing bioavailability.

Disadvantages

• Limited Volume: The nasal cavity can only accommodate a limited volume of liquid, typically around 0.1 to 0.2 mL per nostril.
• Irritation: Some substances may cause irritation or damage to the nasal mucosa.
• Variable Absorption: Factors such as nasal congestion or mucosal health can affect drug absorption.

Clinical Applications

Intranasal administration is used for a variety of medications, including:

• Analgesics: Such as intranasal ketorolac for pain management.
• Hormones: Such as intranasal desmopressin for diabetes insipidus.
• Vaccines: Research is ongoing into intranasal vaccines for influenza and other diseases.
• Emergency Medications: Such as intranasal naloxone for opioid overdose.

Research and Development

Ongoing research is exploring the potential of intranasal delivery for biologics, peptides, and other complex molecules. The development of novel formulations and delivery devices aims to enhance the efficacy and safety of intranasal therapies.

Also see

• Nasal spray
• Drug delivery
• Pharmacokinetics
• Blood-brain barrier

‎